JP2023075230A5 - - Google Patents

Download PDF

Info

Publication number
JP2023075230A5
JP2023075230A5 JP2023035499A JP2023035499A JP2023075230A5 JP 2023075230 A5 JP2023075230 A5 JP 2023075230A5 JP 2023035499 A JP2023035499 A JP 2023035499A JP 2023035499 A JP2023035499 A JP 2023035499A JP 2023075230 A5 JP2023075230 A5 JP 2023075230A5
Authority
JP
Japan
Prior art keywords
polypeptide
chimeric
petiole
head domain
globular head
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023035499A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023075230A (ja
JP7534465B2 (ja
Filing date
Publication date
Priority claimed from PCT/US2018/053099 external-priority patent/WO2019067706A1/en
Application filed filed Critical
Publication of JP2023075230A publication Critical patent/JP2023075230A/ja
Publication of JP2023075230A5 publication Critical patent/JP2023075230A5/ja
Application granted granted Critical
Publication of JP7534465B2 publication Critical patent/JP7534465B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023035499A 2017-09-29 2023-03-08 ヒト化C1q複合体を発現する非ヒト動物 Active JP7534465B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201762565438P 2017-09-29 2017-09-29
US62/565,438 2017-09-29
PCT/US2018/053099 WO2019067706A1 (en) 2017-09-29 2018-09-27 NON-HUMAN ANIMALS EXPRESSING A HUMANIZED C1Q COMPLEX
JP2020518013A JP7242650B2 (ja) 2017-09-29 2018-09-27 ヒト化C1q複合体を発現する非ヒト動物

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2020518013A Division JP7242650B2 (ja) 2017-09-29 2018-09-27 ヒト化C1q複合体を発現する非ヒト動物

Publications (3)

Publication Number Publication Date
JP2023075230A JP2023075230A (ja) 2023-05-30
JP2023075230A5 true JP2023075230A5 (https=) 2023-08-22
JP7534465B2 JP7534465B2 (ja) 2024-08-14

Family

ID=63858187

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020518013A Active JP7242650B2 (ja) 2017-09-29 2018-09-27 ヒト化C1q複合体を発現する非ヒト動物
JP2023035499A Active JP7534465B2 (ja) 2017-09-29 2023-03-08 ヒト化C1q複合体を発現する非ヒト動物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2020518013A Active JP7242650B2 (ja) 2017-09-29 2018-09-27 ヒト化C1q複合体を発現する非ヒト動物

Country Status (18)

Country Link
US (2) US11186848B2 (https=)
EP (2) EP3687287B1 (https=)
JP (2) JP7242650B2 (https=)
KR (2) KR102696334B1 (https=)
CN (2) CN111386039B (https=)
AU (1) AU2018341685A1 (https=)
CA (1) CA3077418A1 (https=)
DK (1) DK3687287T5 (https=)
ES (1) ES2961713T3 (https=)
FI (1) FI3687287T3 (https=)
IL (1) IL273588A (https=)
LT (1) LT3687287T (https=)
PT (1) PT3687287T (https=)
RU (1) RU2020112751A (https=)
SG (1) SG11202002002XA (https=)
SI (1) SI3687287T1 (https=)
WO (1) WO2019067706A1 (https=)
ZA (1) ZA202001389B (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX394999B (es) 2017-09-29 2025-03-24 Regeneron Pharma Animales no humanos que comprenden un locus ttr humanizado y metodos de uso
US11891618B2 (en) 2019-06-04 2024-02-06 Regeneron Pharmaceuticals, Inc. Mouse comprising a humanized TTR locus with a beta-slip mutation and methods of use

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030082546A1 (en) * 1996-11-06 2003-05-01 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US6586251B2 (en) 2000-10-31 2003-07-01 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
ES2329012T3 (es) 2000-11-07 2009-11-20 Zymogenetics, Inc. Receptor del factor de necrosis tumoral humano.
GB0322998D0 (en) 2003-10-01 2003-11-05 Ares Trading Sa Protein
AU2005295269B2 (en) 2004-10-19 2010-05-13 Regeneron Pharmaceuticals, Inc. Method for generating an animal homozygous for a genetic modification
SI1962895T1 (sl) * 2005-12-16 2013-04-30 Regeneron Pharmaceuticals, Inc. Terapevtska uporaba DII4 antagonista in VEGF inhibitorja za inhibiranje tumorske rasti
PL2170389T3 (pl) * 2007-06-12 2015-03-31 Ac Immune Sa Humanizowane przeciwciało przeciw amyloidowi beta
KR102203727B1 (ko) * 2010-03-31 2021-01-18 아블렉시스, 엘엘씨 키메라 항체의 제조를 위한 비-인간 동물의 유전적 조작
US9283271B2 (en) * 2010-12-17 2016-03-15 Neurimmune Holding Ag Human anti-SOD1 antibodies
US9043996B2 (en) * 2011-10-28 2015-06-02 Regeneron Pharmaceuticals, Inc. Genetically modified major histocompatibility complex animals
SI2770821T1 (en) 2011-10-28 2018-01-31 Regeneron Pharmaceuticals, Inc. Genetically modified major histocompatibility complex of mice
FR2996561B1 (fr) 2012-10-09 2016-03-18 Commissariat Energie Atomique Procede de preparation de proteine c1q recombinante
MX2015010841A (es) 2013-02-20 2016-05-09 Regeneron Pharma Modificacion genetica de ratas.
SI2986729T1 (sl) 2013-04-16 2019-02-28 Regeneron Pharmaceuticals, Inc. Ciljana sprememba genoma podgane
WO2015006507A1 (en) * 2013-07-09 2015-01-15 Annexon, Inc. Methods of treatment for alzheimer's disease and huntington's disease
SG10202003996YA (en) 2014-05-05 2020-06-29 Regeneron Pharma Humanized c5 and c3 animals
RU2020122439A (ru) 2014-11-24 2020-09-24 Регенерон Фармасьютикалз, Инк. Не относящиеся к человеку животные, экспрессирующие гуманизированный комплекс cd3
MX394999B (es) 2017-09-29 2025-03-24 Regeneron Pharma Animales no humanos que comprenden un locus ttr humanizado y metodos de uso

Similar Documents

Publication Publication Date Title
JP2023075230A5 (https=)
Gudmundsson et al. Structure of the gene for porcine peptide antibiotic PR-39, a cathelin gene family member: comparative mapping of the locus for the human peptide antibiotic FALL-39.
Bodner et al. The pituitary-specific transcription factor GHF-1 is a homeobox-containing protein
Maucuer et al. Stathmin interaction with a putative kinase and coiled-coil-forming protein domains.
JP2023179457A5 (https=)
Reber-Müller et al. An extracellular matrix protein of jellyfish homologous to mammalian fibrillins forms different fibrils depending on the life stage of the animal
JP2008301828A5 (https=)
KR100538768B1 (ko) 환경 스트레스에 내성을 부여하는 신규한 펩타이드를 포함하는 융합단백질
JP2005520519A (ja) ハイブリッドおよび単鎖メガヌクレアーゼならびにその使用
JP2019500414A5 (https=)
Giga-Hama et al. High–Level Expression of Human Lipocortin I in the Fission Yeast Schizosaccharomyces pombe Using a Novel Expression Vector
JP2024096897A5 (https=)
US20030167477A1 (en) Fusion proteins incorporating lysozyme
RU2015106500A (ru) Новые инсектицидные белки и способы их применения
JPWO2020027010A5 (https=)
Kokubo et al. Involvement of the Bombyx Scr gene in development of the embryonic silk gland
JP2004532037A5 (https=)
Stears et al. Mapping sperm binding domains on the sea urchin egg receptor for sperm
JP2003334088A5 (https=)
Dharamsi et al. CBP1 associates with the Dictyostelium cytoskeleton and is important for normal cell aggregation under certain developmental conditions
Hu et al. Zebrafish eggs used as bioreactors for the production of bioactive tilapia insulin-like growth factors
FI3687287T3 (fi) Humanisoitua c1q-kompleksia ilmentävät jyrsijät
TWI291963B (en) Expression of zebrafish bone morphogenetic protein 4
CN112391366B (zh) 光诱导激活的Dre重组系统
Kang et al. Adaptive evolution of β-defensin gene clusters by gene duplication and loss during environmental changes in mammals